Prognostic value of dipyridamole stress echocardiography in women;Valor prognóstico da ecocardiografia sob estresse com dipiridamol em mulheres

Arquivos Brasileiros de Cardiologia

Volumn 96, Issue 1, 2011, Pages 31-37

  De Almeida, Maria Celita ^a   Markman Filho, Brivaldo ^a,b  

^a Procárdio Diagnósticos   (Brazil)

^b FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

Diagnostic techniques and procedures; Dipyridamole; Echocardiography, stress; Myocardial ischemia; Prognostic; Women

Indexed keywords

AMINOPHYLLINE; ATROPINE; DIPYRIDAMOLE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BRONCHOSPASM; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; DIAGNOSTIC TEST ACCURACY STUDY; DYSLIPIDEMIA; DYSPNEA; ELECTROCARDIOGRAM; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HEADACHE; HEART DEATH; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE WALL MOTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE EXTRASYSTOLE; HUMAN; MAJOR CLINICAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE; PROGNOSIS; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STRESS ECHOCARDIOGRAPHY; THORAX PAIN; UNIVARIATE ANALYSIS; UNSTABLE ANGINA PECTORIS;

ADULT; AGED; AGED, 80 AND OVER; DIPYRIDAMOLE; ECHOCARDIOGRAPHY, STRESS; FEMALE; HUMANS; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; VASODILATOR AGENTS;

EID: 79951595768     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/S0066-782X2010005000156     Document Type: Article

References (41)

1. Diercks DB, Kirl JD. Chest pain units: management of special populations. Cardiol Clin. 2005; 23 (4): 549-57. (Pubitemid 41579045)
2. Canto JG, Shlipak MG, Rogers WJ, Malmgren JA, Frederick PD, Lambrew CT, et al. Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain. JAMA. 2000; 283 (24): 3223-9. (Pubitemid 30422040)
3. Merz NB, Johnson BD, Kelsey PSF, Reis SE, Lewis JF, Reichek N, et al. Diagnostic, prognostic and cost assessment of coronary artery disease in women. Am J Manag Care. 2001; 7 (10): 959-65. (Pubitemid 33048740)
4. Picano E, Bedetti G, Varga A, Cseh E. The comparable diagnostic accuracies of dobutamine-stress and dipyridamole-stress echocardiographies: a metaanalysis. Coron Artery Dis. 2000; 11 (2): 151-9. (Pubitemid 30193054)
5. Pingitore A, Picano E, Varga A, Gigli G, Cortigiani L, Previtali M, et al. Prognosis value of pharmacological stress echocardiography in patients with known or suspected coronary artery disease. J Am Coll Cardiol. 1999; 34 (6): 1769-77.
6. Picano E, Lattanzi F. Dipyridamole echocardiography a new diagnostic window on coronary artery disease. Circulation. 1991; 83 (5 Suppl): III19-26.
7. Sicari R, Nihoyannopoulos P, Evangelista A, Kasprzak J, Lancellotti P, Poldermans D, et al. Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur J Echocardiogr. 2008; 9 (4): 415-37.
8. Picano E, Pingitore A, Conti U, Kozàkovà M, Boem A, Cabani E, et al. Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dipyridamole echocardiography. Eur Heart J. 1993; 14 (9): 1216-22. (Pubitemid 23288292)
9. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002; 105 (4): 539-42. (Pubitemid 34262671)
10. Bach DS, Armstrong WF. Dobutamine stress echocardiography. Am J Cardiol. 1992; 69 (20): 90H-6H.
11. Cortigiani L, Dodi C, Paolini EA, Bernardi D, Bruno G, Nannini E. Prognostic value of pharmacological stress echocardiography in women with chest pain and unknown artery disease. J Am Coll Cardiol. 1998; 32 (7): 1975-81. (Pubitemid 29010464)
12. Piegas LS, Timerman A, Nicolau JC, Mattos LA, Rossi Neto JM, Feitosa, G. Sociedade Brasileira de Cardiologia. III Diretriz sobre tratamento do infarto agudo do miocárdio. Arq Bras Cardiol. 2004; 83 ( supl 4): 7-87.
13. Nicolau JC, Timerman A, Piegas LS, Marim-Neto JA, Rassi A Jr.: Guidelines for unstable angina and non-ST segment elevation myocardial infarction of the Brazilian Society of Cardiology (II Edition, 2007). Arq Bras Cardiol 2007 Abr; 89(4): e89-e131
14. Yusuf S, Hawken S, Ounpuu S. INTERHEART Study Investigations. Effects of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the interheart study): Case-control study. Lancet. 2004; 364 (9438): 937-52. (Pubitemid 39208455)
15. Sitges M, Azqueta M, Paré C. Dobutamine stress echocardiography and exercise eletrocardiography for risk stratification in medically treated unstable angina. J Am Soc Echocardiogr. 2000;13 (12): 1084-90. (Pubitemid 32047831)
16. Sicari R, Picano E, Landi P, Pasanisi E, Venneri L. Pharmacologic stress echocardiography predicts total mortality early after acute myocardial infarction. J Am Soc Echocardiogr. 2004; 17 (2): 114-20. (Pubitemid 38182429)
17. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol. 2002; 39 (7): 1151-8. (Pubitemid 34267418)
18. Multicenter Posinfarction Research Group: Risk stratification and survival after myocardial infarction. N Engl J Med. 1983; 309 (6): 331-6.
19. Morrow DA, Gersh BJ, Braunwald E. Chronic coronary artery disease. In: Zipes DP, Libby P, Bonow RO, Braunwald E, (eds.). Braunwald's heart disease. 7th ed. Philadelphia: Elsevier Saunders; 2005. p.1285-354.
20. Crenshaw JH, Mirvis DM, el-Zeky F, van der Zwaag R, Ramanathan KB, Maddock V, et al. Interactive effects of ST-T wave abnormalities on survival of patients with coronary artery disease. J Am Coll Cardiol. 1991; 18 (2): 413-20.
21. Fragasso G, Lu C, Dabrowski P, Pagnotta P, Sheiban I, Chierchia S. Comparison of stress/rest myocardial perfusion tomography, dipyridamole and dobutamine stress echocardiography for the detection of coronary disease in hypertensive patients with chest pain and positive exercise test. J Am Coll Cardiol. 1999; 34 (2): 441-7.
22. Cortigiani L, Desideri A, Bigi R. Noninvasive assessment of coronary artery disease: the role of stress echocardiography. Ital Heart J. 2001; 2 (4): 250-5. (Pubitemid 32492818)
23. Gibbons RJ, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson TB, et al. ACC/AHA 2002 guideline uptade for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for the Management of Patients with Chronic Stable Angina). 2002. [Acessed on 2008 Aug 21]. Available from http://www.acc.org/clinical/ guidelines/stable/stable.pdf
24. Senior R, Monaghan M, Becher H, Mayet J, Nihoyannopoulos P. Stress echocardiography for the diagnosis and risk stratification of patients with suspected or known coronary artery disease: a critical appraisal. Supported by the British Society of Echocardiography. Heart. 2005; 91 (4): 427-36.
25. Markman Filho B, Almeida MC, Markman M, Chaves A, Moretti MA, Ramires JAF, et al. Estratificando o risco na angina instável com a ecocardiografia sob estresse com dobutamina. Arq Bras Cardiol. 2006; 87 (3): 294-9.
26. Marwick T, D'Hondt AM, Baudhuin T, Willemart B, Wijns W, Detry JM, et al. Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease: combination with echocardiography or scintigraphy, or both? J Am Coll Cardiol. 1993; 22 (1): 159-67.
27. Mieres JH, Shaw LJ, Arai A, Budoff MJ, Flamm SD, Hundley WG, et al. Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease. Circulation. 2005; 111 (5): 682-96.
28. Marwick TH, Nemec JJ, Pashkow FJ, Stewart WJ, Salcedo EE. Accuracy and limitations of exercise echocardiography in a routine clinical setting. J Am Coll Cardiol. 1992; 19 (1): 74-81.
29. Geleijnse ML, Krenning BJ, Soliman OI, Nemes A, Galema TW, ten Cate FJ. Dobutamine stress echocardiography for the detection of coronary artery disease in women. Am J Cardiol. 2007; 99 (5): 714-7.
30. Smanio P. Cardiovascular disease in diabetic women without cardiac symptoms. Arq Bras Endocrinol Metab. 2007; 51 (2): 305-11.
31. Borges AC, Pingitore A, Cordovil A, Sicari R, Baumann G, Picano E. Heterogeneity of left ventricular regional wall thickening following dobutamine infusion in normal human subjects. Eur Heart J. 1995; 16 (11): 1726-30. (Pubitemid 126679050)
32. Bugiardini R, Manfrini O, Pizzi C, Fontana F, Morgagni G. Endothelial function predicts future development of coronary artery disease: a study of women with chest pain and normal coronary angiograms. Circulation. 2004; 109 (21): 2518-23.
33. Sicari R, Palinkas A, Pasanisi EG, Venneri L, Picano E. Long-term survival of patients with chest pain syndrome and angiographically normal or near-normal coronary arteries: the additional prognostic value of dipyridamole echocardiography test (DET). Eur Heart J. 2005; 26 (20): 2136-41. (Pubitemid 41407996)
34. Dodi C, Cortigiani L, Masini M, Olivotto I, Azzarelli A, Nannini E. The incremental prognostic value of pharmacological stress echo over exercise electrocardiography in women with chest pain of unknown origin. Eur Heart J. 2001; 22 (2): 145-52. (Pubitemid 32619636)
35. Mahenthiran J, Bangalore S, Yao SS, Chaudhry FA. Comparison of prognostic value of stress echocardiography versus stress electrocardiography in patients with suspected coronary artery disease. Am J Cardiol. 2005; 96 (5): 628-34. (Pubitemid 41207301)
36. Shaw LJ, Vasey C, Sawada S, Rimmerman C, Marwick TH. Impact of gender on risk stratification by exercise and dobutamine stress echocardiography: long-term mortality in 4234 women and 6898 men. Eur Heart J. 2005; 26 (5): 447-56. (Pubitemid 40314760)
37. Biagini E, Elhendy A, Schinkel AF, Rizzello V, van Domburg RT, Krenning BJ, et al. Comparison of all-cause mortality in women with known or suspected coronary artery disease referred for dobutamine stress echocardiography with normal versus abnormal test results. Am J Cardiol. 2005; 95 (9): 1072-5. (Pubitemid 40544311)
38. Minardi G, Manzara CC, Pulignano G, Carmenini E, Gaudio C, Giovannini E. Safety and diagnostic accuracy of intravenous accelerated high-dose dipyridamole-atropine stress echocardiography. Ital Heart J. 2002; 3 (12): 726-9. (Pubitemid 36378114)
39. Cortigiani L, Picano E, Coletta C, Chiarella F, Mathias W, Gandolfo N, et al. Safety, feasibility, and prognostic implications of pharmacologic stress echocardiography in 1482 patients evaluated in an ambulatory setting. Am Heart J. 2001; 141 (4): 621-9. (Pubitemid 32260731)
40. Mathias Jr W, Arruda A, Santos FC, Arruda AL, Mattos E, Osório A, et al. Safety of dobutamine-atropine stress echocardiography: a prospective experience of 4033 consecutive studies. J Am Soc Echocardiogr. 1999; 12 (10): 785-91. (Pubitemid 29489402)
41. Picano E, Marini C, Pirelli S, Maffei S, Bolognese L, Chiriatti G, et al. Safety of intravenous high-dose dipyridamole echocardiography: the Echo-Persantine International Cooperative Study Group. Am J Cardiol. 1992; 70 (2): 252-8.